Annual Drug Patent Expirations for LUMAKRAS
Lumakras is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has eigthy-three patent family members in thirty-three countries.
The generic ingredient in LUMAKRAS is sotorasib. One supplier is listed for this compound. Additional details are available on the sotorasib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
